Histamine H<sub>3</sub>and H<sub>4</sub>receptors as novel drug targets
Ekaterini Tiligada(National and Kapodistrian University of Athens), Holger Stark(Heinrich Heine University Düsseldorf), Kerstin Sander(Goethe University Frankfurt), Evangelia Zampeli(National and Kapodistrian University of Athens)
Cited by 142
Related Papers
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
|Pharmacological Reviews|2015|558
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
|Journal of Medicinal Chemistry|2018|476
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function
|Nature Medicine|2003|381
DOGS: Reaction-Driven de novo Design of Bioactive Compounds
|PLoS Computational Biology|2012|264
Neurochemical and Behavioral Effects of Ciproxifan, A Potent Histamine H3-Receptor Antagonist
|Journal of Pharmacology and Experimental Therapeutics|1998|240